Literature DB >> 7844066

Septicaemia in the newborn and elderly.

W R Gransden1, S J Eykyn, I Phillips.   

Abstract

Analysis of 5304 episodes of septicaemia at St Thomas' Hospital showed that both the elderly (> 65 years) and neonates accounted for increasing proportions between 1969 and 1992. In particular the increase was greatest for patients aged over 84 years who accounted for 3% of episodes in adults with community-acquired septicaemia in the 1970s compared with 13% in the 1990s. The change may be explained partly by demographic factors. The majority (85-90%) of elderly patients presented with fever, or leucocytosis or both. The urinary and gastrointestinal tracts were the most common foci for the elderly and they were less likely than other adults to have iv access associated sepsis. Among neonates Escherichia coli septicaemia became less common whereas there was little changes in the incidence of group B streptococcal septicaemia; coagulase-negative staphylococcal infection became more common. Overall mortality declined for both neonates and elderly patients. Poor outcome appeared related to the focus of infection, febrile response and age in the elderly and to the time of onset and organism in neonates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7844066     DOI: 10.1093/jac/34.suppl_a.101

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Increase in bloodstream infections in Finland, 1995-2002.

Authors:  K Skogberg; O Lyytikäinen; P Ruutu; J Ollgren; J P Nuorti
Journal:  Epidemiol Infect       Date:  2007-03-05       Impact factor: 2.451

Review 2.  Bacteraemia in the very old. Features and treatment.

Authors:  L Leibovici
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

3.  Bacteremia associated with pressure ulcers: a prospective cohort study.

Authors:  Elena Espejo; Marta Andrés; Rosa-Maria Borrallo; Emma Padilla; Enric Garcia-Restoy; Feliu Bella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-26       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.